Table 1.
Sample sources | ESBL-producing GNB n = 36 (%) |
Carbapenem resistance GNB n = 139 (%) |
Total n=175 (%) |
||
| |||||
Male | Female | Male | Female | ||
Blood | 2 (8.7) | 1 (7.7) | 14 (14.4) | 11 (26.2) | 28 (16.0) |
Central vein puncture | 0 (0.0) | 1 (7.7) | 6.0 (6.2) | 0 (0.0) | 7 (4.0) |
Sputum | 9 (39.1) | 1 (7.7) | 43 (44.3) | 18 (42.9) | 71 (40.6) |
Urine culture | 5 (21.8) | 8 (61.5) | 16 (16.5) | 6 (14.2) | 35 (20.0) |
Wound | 7 (30.4) | 2 (15.4) | 17 (17.5) | 7 (16.7) | 33 (18.9) |
Broncho alveolar lavage | 0 (0.0) | 0 (0.0) | 1 (1.1) | 0 (0.0) | 1 (0.5) |
Total | 23 (63.9) | 13 (36.1) | 97 (69.8) | 42 (30.2) | 175 (100.0) |
ESBL: Extended-Spectrum Beta-Lactamase; GNB: Gram-negative bacteria